Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure

Schönegger R, Kern-Kim J, Hidaka Y
Record ID 32018015873
English
Authors' objectives: Implantable pulmonary artery pressure telemonitoring aims to detect early haemodynamic deterioration and enable early therapy adjustment in NYHA III heart failure.
Authors' results and conclusions: High- to moderate-certainty evidence indicates that PAP telemonitoring significantly reduces hospitalisations compared with standard care, with no significant effects on mortality, urgent care, or use of guideline-directed medical therapy. The safety profile is favourable with rare complications (moderate certainty).
Authors' recommendations: Effects on health-related quality of life remain uncertain due to high risk of bias for patient-reported outcomes. However, real-world effectiveness depends on structured care pathways and adequate resources.
Authors' methods: To evaluate the clinical effectiveness and safety, seven studies (3 RCTs, 4 observational studies) were included.
Details
Project Status: Completed
URL for project: https://aihta.at/page/bewertung-medizinischer-einzelleistungen-mel-berichte/en
Year Published: 2026
URL for published report: https://eprints.aihta.at/1616/1/DSD_119_Update2026.pdf
URL for additional information: https://eprints.aihta.at/1616/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Pulmonary Artery
  • Heart Failure
  • Wireless Technology
  • Arterial Pressure
  • Remote Patient Monitoring
  • Blood Pressure Monitoring, Ambulatory
Keywords
  • Pulmonary artery pressure
  • implantable telemonitoring
  • heart failure
  • NYHA III
  • hospitalisations
Contact
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Josefstaedter Strasse 39, A-1080 Vienna, Austria
Contact Name: office@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.